Moreover, about 30% of NK-AML [6] is affected by FLT3-internal tandem duplication (ITD) resulting in the deregulation of flt3 kinase activity and determining a worse clinical outcome, even in the presence of NPM1 mutations [7,8]. Here, FLT3 is linked to acute myeloid leukemia.